MEGAN BOYTEK: Open Payments
NPI 1225624034 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 70 payments from 18 companies in 2025. Trend: 2023 $699 · 2024 $1,487 · 2025 $1,471
Food & beverage: $1,424Education: $46
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 11 | $238 |
| Mallinckrodt Hospital Products Inc. | 9 | $205 |
| Novartis Pharmaceuticals Corporation | 13 | $196 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| Travere Therapeutics, Inc. | 6 | $120 |
| Lilly USA, LLC | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Recor Medical Inc | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Vifor Pharma, Inc. | 2 | $54 |
Products named: TARPEYO, TERLIVAZ, Fabhalta, JARDIANCE, FARXIGA, Kerendia, Paradise Ultrasound Renal Denervation System, Veltassa.
Industry payments across WV — which companies pay providers there.
